Who owns Kyverna Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of KYTX from SEC Form 13F filings across 120 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 120 institutions disclosed 37.6M shares of Kyverna Therapeutics, Inc. worth $335.1M — about 61.8% of shares outstanding; the largest disclosed holder is GordonMD Global Investments LP. Source: SEC Form 13F filings, parsed by EvidInvest.
120
13F holders
$335.1M
value, 2026 filers
61.8%
of shares outstanding (37.6M sh)
31
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of KYTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | 4.2M | $37.8M | 18.3% | 7% | 0.0% |
| 2 | GILEAD SCIENCES, INC. | 4.1M | $36.8M | 2.2% | 6.8% | 0.0% |
| 3 | BlackRock, Inc. | 3.1M | $27.9M | 0.0% | 5.1% | +257.4% |
| 4 | Bain Capital Life Sciences Investors, LLC | 2.9M | $25.7M | 1.5% | 4.7% | -7.2% |
| 5 | AIGH Capital Management LLC | 2.8M | $24.9M | 1.6% | 4.6% | +39.8% |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.0M | $17.8M | 0.2% | 3.3% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | $16.9M | 0.0% | 3.1% | +6.4% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.2M | $10.6M | 0.0% | 1.9% | -23.7% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $9.4M | 0.0% | 1.7% | +147.6% |
| 10 | Insight Holdings Group, LLC | 989,054 | $8.8M | 0.7% | 1.6% | 0.0% |
| 11 | MORGAN STANLEY | 982,307 | $8.8M | 0.0% | 1.6% | +0.5% |
| 12 | STATE STREET CORP | 982,233 | $8.8M | 0.0% | 1.6% | +610.2% |
| 13 | Propel Bio Management, LLC | 883,198 | $7.9M | 4.1% | 1.5% | +37.1% |
| 14 | Woodline Partners LP | 845,325 | $7.5M | 0.0% | 1.4% | 0.0% |
| 15 | MILLENNIUM MANAGEMENT LLC | 639,780 | $5.7M | 0.0% | 1.1% | -36.4% |
| 16 | MBB PUBLIC MARKETS I LLC | 614,477 | $5.5M | 0.6% | 1% | 0.0% |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $4.5M | 0.0% | 0.8% | 0.0% |
| 18 | D. E. Shaw & Co., Inc. | 469,346 | $4.2M | 0.0% | 0.8% | -35.0% |
| 19 | WELLS FARGO & COMPANY/MN | 373,009 | $3.3M | 0.0% | 0.6% | +226.1% |
| 20 | UBS Group AG | 365,574 | $3.3M | 0.0% | 0.6% | -18.7% |
| 21 | GOLDMAN SACHS GROUP INC | 335,230 | $3.0M | 0.0% | 0.6% | +57.5% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 333,899 | $3.0M | 0.0% | 0.5% | -9.1% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 319,666 | $2.8M | 0.0% | 0.5% | +51.4% |
| 24 | NORTHERN TRUST CORP | 315,354 | $2.8M | 0.0% | 0.5% | +304.1% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 310,632 | $2.8M | 0.0% | 0.5% | -24.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.